Litcius/Paper detail

Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors

Reaz Uddin, Khurshid Jalal, Kanwal Khan, Zaheer Ul‐Haq

2021Journal of Molecular Structure21 citationsDOIOpen Access PDF

Topics & Concepts

SimeprevirVirologyProteaseIn silicoChemistryDocking (animal)Drug repositioningHepatitis C virusPharmacologyDrugVirusEnzymeMedicineBiochemistryRibavirinGeneNursingComputational Drug Discovery MethodsHepatitis C virus researchSARS-CoV-2 and COVID-19 Research
Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors | Litcius